TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Branded Generics Market – By Therapeutic Application
1.3.2 APAC Branded Generics Market – By Distribution Channel
1.3.3 APAC Branded Generics Market – By Drug Class
1.3.4 APAC Branded Generics Market – By Formulation Type
1.3.5 APAC Branded Generics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Branded Generics Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.2.1 Experts Opinion
5. APAC Branded Generics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Branded Generics Becoming Popular
5.1.2 Branded Generics Being Promoted by Various Government Initiatives
5.2 Market Restraints
5.2.1 Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications
5.3 Market Opportunities
5.3.1 Product Differentiation Providing New Opportunities
5.4 Future Trends
5.4.1 Encouraging Utility of Branded Generics by Healthcare Providers and Professionals
5.5 Impact Analysis
6. Branded Generics Market– APAC Analysis
6.1 APAC Branded Generics Market Revenue Forecast and Analysis
6.2 APAC Branded Generics Market, By Country - Forecast and Analysis
7. APAC Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application
7.1 Overview
7.2 APAC Branded Generics Market, By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology Market Revenue and Forecast to 2028 (US$ Billion)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.5 Diabetes
7.5.1 Overview
7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Billion)
7.6 Neurology
7.6.1 Overview
7.6.2 Neurology Market Revenue and Forecast to 2028 (US$ Billion)
7.7 Gastrointestinal Diseases
7.7.1 Overview
7.7.2 Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.8 Dermatology Diseases
7.8.1 Overview
7.8.2 Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.9 Analgesics and Anti-Inflammatory
7.9.1 Overview
7.9.2 Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)
7.10 Others
7.10.1 Overview
7.10.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
8. APAC Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel
8.1 APAC Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)
8.2 Hospital Pharmacies
8.2.1 Overview
8.2.2 Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.3 Retail Pharmacies
8.3.1 Overview
8.3.2 Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.4 Online Pharmacies
8.4.1 Overview
8.4.2 Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.5 Drug Stores
8.5.1 Overview
8.5.2 Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9. APAC Branded Generics Market Analysis and Forecast to 2028 by Drug Class
9.1 APAC Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)
9.2 Alkylating Agents
9.2.1 Overview
9.2.2 Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.3 Antimetabolites
9.3.1 Overview
9.3.2 Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.4 Hormones
9.4.1 Overview
9.4.2 Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.5 Anti-hypertensive
9.5.1 Overview
9.5.2 Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.6 Lipid Lowering Drugs
9.6.1 Overview
9.6.2 Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.7 Anti-Depressants
9.7.1 Overview
9.7.2 Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.8 Anti-psychotics
9.8.1 Overview
9.8.2 Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.9 Anti-epileptic
9.9.1 Overview
9.9.2 Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.10 Others
9.10.1 Overview
9.10.2 Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
10. APAC Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type
10.1 Overview
10.2 APAC Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)
10.3 Oral
10.3.1 Overview
10.3.2 Oral Market Revenue and Forecast to 2028 (US$ Billion)
10.4 Parenteral
10.4.1 Overview
10.4.2 Parenteral Market Revenue and Forecast to 2028 (US$ Billion)
10.5 Topical
10.5.1 Overview
10.5.2 Topical Market Revenue and Forecast to 2028 (US$ Billion)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
11. APAC Branded Generics Market Revenue and Forecasts to 2028 Country Analysis
11.1 Overview
11.1.1 APAC: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)
11.1.1.1 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.1.1 Overview
11.1.1.1.2 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.1.3 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.1.1.1.4 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.1.1.1.5 Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.1.6 Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.2.1 Overview
11.1.1.2.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.2.3 China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.1.1.2.4 China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.1.1.2.5 China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2.6 China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3 India Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.3.1 Overview
11.1.1.3.2 India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.3.3 India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.1.1.3.4 India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.1.1.3.5 India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3.6 India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.4.1 Overview
11.1.1.4.2 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.4.3 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.1.1.4.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.1.1.4.5 South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.4.6 South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.5 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.5.1 Overview
11.1.1.5.2 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)
11.1.1.5.3 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.1.1.5.4 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.1.1.5.5 Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.5.6 Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6 Rest of APAC: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of APAC: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6.3 Rest of APAC: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
11.1.1.6.4 Rest of APAC: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
11.1.1.6.5 Rest of APAC: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6.6 Rest of APAC: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
12. Branded Generics Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MYLAN N.V.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bausch Health Companies Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Lupin
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Sanofi
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ASTRAZENECA PLC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Dr. Reddy's Laboratories
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Par Pharmaceuticals, INC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Sandoz International GMBH
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Aspen Holdings
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Hetero
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 2. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 3. Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 4. Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 5. China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 6. China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 7. China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 8. China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 9. India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 10. India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 11. India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 12. India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 13. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 14. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 15. South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 16. South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 17. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 18. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 19. Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 20. Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 21. Rest of APAC: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)
Table 22. Rest of APAC: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)
Table 23. Rest of APAC: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 24. Rest of APAC: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary of Terms